YeeMeng
2021-08-23
Accumulate
Vivos Therapeutics Stock Is Moving Higher On FDA Approval For Its Sleep Apnea Device
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
5
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":835268267,"tweetId":"835268267","gmtCreate":1629721516759,"gmtModify":1633682959929,"author":{"id":3582597737343890,"idStr":"3582597737343890","authorId":3582597737343890,"authorIdStr":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":12,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Accumulate</p></body></html>","htmlText":"<html><head></head><body><p>Accumulate</p></body></html>","text":"Accumulate","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/835268267","repostId":1102999278,"repostType":4,"repost":{"id":"1102999278","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1629721328,"share":"https://www.laohu8.com/m/news/1102999278?lang=&edition=full","pubTime":"2021-08-23 20:22","market":"us","language":"en","title":"Vivos Therapeutics Stock Is Moving Higher On FDA Approval For Its Sleep Apnea Device","url":"https://stock-news.laohu8.com/highlight/detail?id=1102999278","media":"Benzinga","summary":"The FDA has granted 510(k) clearance to Vivos Therapeutics Inc's mmRNA (modified mandibular Repositi","content":"<p>The FDA has granted 510(k) clearance to <b><a href=\"https://laohu8.com/S/VVOS\">Vivos Therapeutics</a> Inc's</b> mmRNA (modified mandibular Repositioning Nighttime Appliance) obstructive sleep apnea (OSA) device.</p>\n<p>The device is indicated for mild to moderate OSA, sleep-disordered breathing, and snoring in adults.</p>\n<p>The approval paves the way for expanded insurance reimbursement coverage for the mmRNA device and potential future government contracts and reimbursement.</p>\n<p>Separately, the FDA has denied Vivos' previously submitted, additional 510(k) application for its DNA appliance.</p>\n<p>The DNA appliance is already registered with the FDA as a Class I device for palatal expansion and is currently being used by Vivos-trained clinicians accordingly.</p>\n<p>Vivos expects to appeal the FDA's decision or resubmit the 510(k) application to the FDA in the coming weeks.</p>\n<p><b>Price Action:</b> VVOS shares are up 41.9% at $5.45 during the premarket session on the last check Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vivos Therapeutics Stock Is Moving Higher On FDA Approval For Its Sleep Apnea Device</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVivos Therapeutics Stock Is Moving Higher On FDA Approval For Its Sleep Apnea Device\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-08-23 20:22</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>The FDA has granted 510(k) clearance to <b><a href=\"https://laohu8.com/S/VVOS\">Vivos Therapeutics</a> Inc's</b> mmRNA (modified mandibular Repositioning Nighttime Appliance) obstructive sleep apnea (OSA) device.</p>\n<p>The device is indicated for mild to moderate OSA, sleep-disordered breathing, and snoring in adults.</p>\n<p>The approval paves the way for expanded insurance reimbursement coverage for the mmRNA device and potential future government contracts and reimbursement.</p>\n<p>Separately, the FDA has denied Vivos' previously submitted, additional 510(k) application for its DNA appliance.</p>\n<p>The DNA appliance is already registered with the FDA as a Class I device for palatal expansion and is currently being used by Vivos-trained clinicians accordingly.</p>\n<p>Vivos expects to appeal the FDA's decision or resubmit the 510(k) application to the FDA in the coming weeks.</p>\n<p><b>Price Action:</b> VVOS shares are up 41.9% at $5.45 during the premarket session on the last check Monday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VVOS":"Vivos Therapeutics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102999278","content_text":"The FDA has granted 510(k) clearance to Vivos Therapeutics Inc's mmRNA (modified mandibular Repositioning Nighttime Appliance) obstructive sleep apnea (OSA) device.\nThe device is indicated for mild to moderate OSA, sleep-disordered breathing, and snoring in adults.\nThe approval paves the way for expanded insurance reimbursement coverage for the mmRNA device and potential future government contracts and reimbursement.\nSeparately, the FDA has denied Vivos' previously submitted, additional 510(k) application for its DNA appliance.\nThe DNA appliance is already registered with the FDA as a Class I device for palatal expansion and is currently being used by Vivos-trained clinicians accordingly.\nVivos expects to appeal the FDA's decision or resubmit the 510(k) application to the FDA in the coming weeks.\nPrice Action: VVOS shares are up 41.9% at $5.45 during the premarket session on the last check Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":28,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":10,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/835268267"}
精彩评论